Jung HA, Park KU, Cho S, Lim J, et al. A Phase II Study of Nivolumab Plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11). Clin Cancer Res 2022 Jul 12. pii: 706988. doi: 10.1158/1078-0432.CCR-22-1238.
PMID: 35819451